GL1X · GenesisL1 explorer

MolNFT v1 · #63278 · protein

HIV GP41 six-helix bundle containing a mutant chr alpha- peptide sequence

3F4Y · Envelope glycoprotein GP160: “HIV GP41 six-helix bundle containing a mutant chr alpha- peptide sequence”. X-ray diffraction, 2 ligands (ACE, NH2). MolNFT v1 #63278 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3F4Y
Type
protein
Length
222 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Envelope glycoprotein GP160; Mutant peptide derived from HIV GP41 chr domain
UniProt
P04580
Ligands
ACE, NH2

Structure

x-ray diffraction · 2 distinct chains · 89% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, CEnvelope glycoprotein GP160protein3694% helix, 0% strandP04580
D, E, FMutant peptide derived from HIV GP41 chr domainprotein3884% helix, 0% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · 6 copies · chains A, E, B, F, C, D
  • NH2 · Amino group · ion · 6 copies · chains A, B, C, D, E, F

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

9 interfaces between chains.

  • A–D · 793 Ų buried · 12 hydrogen bonds · protein-protein
  • C–F · 785 Ų buried · 8 hydrogen bonds · protein-protein
  • B–E · 758 Ų buried · 5 hydrogen bonds · protein-protein
  • A–C · 701 Ų buried · 8 hydrogen bonds · protein-protein
  • A–B · 676 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 covalent (covalent ligand).

Compared structures

  • 3F4Y · HIV gp41 six-helix bundle containing a mutant CHR alpha-peptide sequence · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.